MLANA and melanoma: So far, despite S100 immunostaining with the 97–100% sensitivity and 75–87% specificity, additional higher specificity markers such as HMB-45 (69–93%), and MART-1/Melan-A (75–92%) have been used to assist in the differential diagnosis for melanoma [11].